GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

With a flood of competitors and conglomerates eyeing the market, brands are working to create a buzz in the new world of ...

Campbell Soup Co. announced its intention to change its name just over two months ago, saying it wanted to instead be known as the (slightly shorter) Campbell’s Co. Shareholders overwhelmingly ...

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Parenthood comes with a plethora of challenges—and one of them may be picking a suitable name for the baby. While there are millions to choose from, certain trends emerge each year. As USA Today ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor.

The Ministry of Food and Drug Safety (MFDS) approved South Korea’s first denosumab (Prolia/Xgeva) biosimilars, developed by Celltrion Inc. under the brand names of Stoboclo/Osenvelt (CT-P41) for ...

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' drug for the treatment of a type of biliary tract cancer ...

Lifestyle expert Preston Konrad and branding veteran Lisa Manice have connected with some operational muscle to take the ...

The Kimberly-Clark brand tapped Turner Duckworth and FCB for a brand refresh and new campaign, respectively, as it marks its 100-year anniversary. New visuals trade a sense of staid luxury for more ...